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Abstract
Background
Late-onset bloodstream infection (LO-BSI) is a common complication of prematurity, and
lack of timely diagnosis and treatment can have life-threatening consequences. We sought
to identify clinical characteristics and microbial signatures in the gastrointestinal microbiota
preceding diagnosis of LO-BSI in premature infants.
Method
Daily faecal samples and clinical data were collected over two years from 369 premature
neonates (<32 weeks gestation). We analysed samples from 22 neonates who developed
LO-BSI and 44 matched control infants. Next-generation sequencing of 16S rRNA gene
regions amplified by PCR from total faecal DNA was used to characterise the microbiota
of faecal samples preceding diagnosis from infants with LO-BSI and controls. Culture of
selected samples was undertaken, and bacterial isolates identified using MALDI-TOF. Anti-
biograms from bloodstream and faecal isolates were compared to explore strain similarity.
Results
From the week prior to diagnosis, infants with LO-BSI had higher proportions of faecal aer-
obes/facultative anaerobes compared to controls. Risk factors for LO-BSI were identified by
multivariate analysis. Enterobacteriaceal sepsis was associated with antecedent multiple
lines, low birth weight and a faecal microbiota with prominent Enterobacteriaceae. Staphylo-
coccal sepsis was associated with Staphylococcus OTU faecal over-abundance, and the
number of days prior to diagnosis of mechanical ventilation and of the presence of centrally-
placed lines. In 12 cases, the antibiogram of the bloodstream isolate matched that of a com-
ponent of the faecal microbiota in the sample collected closest to diagnosis.
PLOS ONE | DOI:10.1371/journal.pone.0132923 July 13, 2015 1 / 14
OPEN ACCESS
Citation: Shaw AG, Sim K, Randell P, Cox MJ,
McClure ZE, Li M-S, et al. (2015) Late-Onset
Bloodstream Infection and Perturbed Maturation of
the Gastrointestinal Microbiota in Premature Infants.
PLoS ONE 10(7): e0132923. doi:10.1371/journal.
pone.0132923
Editor: Jörn-Hendrik Weitkamp, Vanderbilt
University, UNITED STATES
Received: April 21, 2015
Accepted: June 21, 2015
Published: July 13, 2015
Copyright: © 2015 Shaw et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: 16S rRNA amplicon
data have been deposited at the European
Nucleotide Archive under accession number
PRJEB6345.
Funding: This work was supported by funding from
Meningitis Now, https://www.meningitisnow.org/
[WMNP_35505] (AGS); the Winnicott Foundation,
http://www.winnicott.org.uk/ [WMNP_26859] (AGS,
KS, PR, PRL, JSK); the Livanos Trust (MSL); the
Wellcome Trust, http://www.wellcome.ac.uk/ (MFM,
WOCMC); the Asmarley Trust (MJC); and the
National Institute for Health Research (NIHR)
Conclusions
The gastrointestinal tract is an important reservoir for LO-BSI organisms, pathogens trans-
locating across the epithelial barrier. LO-BSI is associated with an aberrant microbiota, with
abundant staphylococci and Enterobacteriaceae and a failure to mature towards predomi-
nance of obligate anaerobes.
Introduction
Late-onset bloodstream infection (LO-BSI) (occurring> 72 hours after birth) is a common
complication of prematurity, affecting up to 24.4% of very low birth weight (VLBW) infants
(<1,500g).[1] Causative organisms are traditionally grouped by likely mode of acquisition—
during insertion of vascular access catheters: Staphylococcus aureus, coagulase-negative staphy-
lococci (CoNS), and other Gram-positive skin commensal bacteria;[2–4] and by translocation
across the epithelial surface of the immature gastrointestinal (GI) tract: members of the infant
gastrointestinal microbiota, in particular Gram-negative enteric bacteria, which account for ca.
20% of all LO-BSI.[5] Mortality is high—ca 25% and 40% for infections caused by Gram-posi-
tive and Gram-negative organisms respectively [6]–as is morbidity in survivors: a fourfold
increased risk of cerebral palsy and approximately twofold increased risk of neurodevelopmen-
tal impairment in the case of Gram-positive LO-BSI.[7]
Host factors predisposing VLBW infants to LO-BSI include an immature and naïve immune
system with low levels of passively acquired (maternal) antibody,[8] and fragile skin/mucosal
surfaces.[3] These factors, combined with the risks for infection inherent in the delivery of
care in the neonatal intensive care unit (NICU) environment: the presence of invasive devices
(intravenous (IV) catheters, endotracheal tubes, nasogastric tubes etc.); administration of par-
enteral nutrition; treatment with multiple courses of broad-spectrum antibiotics; and exposure
to antibiotic-resistant organisms;[9] explain why these infants have the highest rates of nosoco-
mial BSIs in the population.[6] Surveillance culture of faeces has been proposed for predicting
risk of Gram-negative LO-BSI,[10] but has limited application beyond the search for specific
pathogens. Addressing the source of infection is paramount for prevention. Strategies to reduce
CoNS and S. aureus BSIs have centered on good hand hygiene and IV line site care.
We hypothesised that antecedent biomarkers of LO-BSI—clinical features and particular
compositions of the developing GI microbiota reflected in the faecal microbiota—may provide
an early warning of impending infection and indicate the likely causative organism. To test our
hypothesis, we collected detailed daily clinical data and almost every faecal sample passed from
birth from>95% of VLBW infants born at our two-site tertiary neonatal unit over a two year
period. Each infant who developed LO-BSI was matched to two controls, and the evolving fae-
cal microbiota in samples collected in the period preceding infection characterised on the basis
of variation in domains of the 16S rRNA gene revealed by next-generation sequencing.
Patients and Methods
Study population
Infants born at<32 completed weeks of gestation admitted to one of the two Imperial College
Healthcare NHS Trust NICUs (one at St. Mary’s Hospital, the other at Queen Charlotte’s and
Chelsea Hospital) between January 2011 and December 2012 were eligible for inclusion in the
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study unless considered to be in extremis in the first days of life. The NICU is a tertiary center
with ~700 admissions per annum. 369 of 388 eligible infants were recruited.
Both hospitals have identical protocols for feeding, prescription of antibiotic and antifungal
drugs and the placing of invasive lines (umbilical venous and arterial catheters, and percutane-
ous intravenous long lines). Staff members work across both sites. Probiotics, H2 receptor
antagonists, and proton pump inhibitors are not used on the unit. Detailed daily clinical infor-
mation was collected from the patients’ records.
Ethics declaration
The study ‘Defining the Intestinal Microbiota in Premature Infants’ (ClinicalTrials.gov Identi-
fier NCT01102738) was approved by West London Research Ethics Committee 2, United
Kingdom (Reference number: 10/H0711/39). Parents gave written informed consent for their
infant to participate in the study.
Sample collection
We collected almost every faecal sample produced by each participant from the point of recruit-
ment until discharge. Samples were collected by nursing staff from diapers using a sterile spat-
ula, placed in a sterile DNAase-, RNAase-free Eppendorf tube, stored in a -20°C freezer on the
neonatal unit within two hours of collection, and stored at -80°C within five days.
Case definition, control selection and clinical management
An eligible case for the study was defined as an infant suffering from LO-BSI (organism iso-
lated on/after day three of life), diagnosed using the Vermont Oxford Network criteria,[11]
and without preceding or concurrent necrotizing enterocolitis (NEC). Infants with early-onset
sepsis were excluded by definition. A diagnosis of BSI attributable to CoNS was based on all of
the following three criteria being fulfilled: CoNS isolated from the blood culture, clinical signs
of sepsis, IV antibacterial therapy for at least five days after blood culture or until death. Blood
cultures were collected under sterile technique and processed using the automated Bactec FX
system (BD). Blood isolates were identified by API for the first six months of the study and
MALDI-TOF for the remaining eighteen. The diagnosis was made by the attending neonatal
consultant and confirmed by an independent neonatologist. Two ‘sequencing control’ infants
(no BSI, NEC or culture positive infections diagnosed during admission), of the same postnatal
age as each BSI case, were selected based (in order of priority) on gestational age (accounting
for prematurity related factors such as gut maturity) and mode of delivery. All such potentially
confounding factors were included in the statistical analysis, allowing identification of any that
could influence the results. Investigators were not involved in clinical care.
Bacterial DNA extraction
Faecal samples (200 mg) were processed using the FastDNA SPIN Kit for Soil (MP Biomedi-
cals), incorporating a bead-beating step for mechanical disruption of cells. We have established
that this effectively lyses Gram-positive and-negative bacteria in faecal samples (unpublished
data). Extractions were performed following the manufacturer’s protocol except that the final
elution step was into TRIS (10 mM) low-ethylenediaminetetraacetic acid (EDTA) (0.1 mM)
buffer.
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Polymerase Chain Reaction amplification and pyrosequencing of the
V3-V5 regions of the bacterial 16S rRNA gene
The V3-V5 region of bacterial 16S rRNA genes was amplified from each DNA sample using a
primer pair tagged with individually unique 12-bp error-correcting Golay barcodes.[12–14]
Polymerase Chain Reaction (PCR) was performed as previously described.[15] Replicate
amplicons were pooled and purified, and pyrosequencing runs were carried out on a 454 Life
Sciences GS FLX (Roche) following the Roche Amplicon Lib-L protocol. Replicate samples
were spread over all sequencing runs as internal controls and negative controls were included
to verify reagents were uncontaminated.
Bioinformatics
Shotgun processed data were denoised using AmpliconNoise [16] as part of the ‘Quantitative
Insights Into Microbial Ecology’ v1.5.0 package [17] followed by chimera-removal with Chi-
meraSlayer.[18] Sequences were aligned using the SILVA rRNA database (SSU_REF108)[19]
for reference and clustered at 97% sequence identity using the UCLUST algorithm [20] into
operational taxonomic units (OTUs). Representative sequences were selected and classified
using the Ribosomal Database Project Classifier.[21] Rarefaction was performed, removing
heterogeneity of sequencing reads per sample.
Data availability
16S rRNA amplicon data have been deposited at the European Nucleotide Archive under
accession number PRJEB6345.
Bacterial culture and antibiograms
Bacteria were cultured from the frozen faecal sample collected closest before the day of diagno-
sis of LO-BSI (D0) from every case and paired contemporaneous controls (termed ‘culture con-
trols’). CNA agar plates (Oxoid) were used to select for Staphylococcus and Streptococcus spp.
and CHROMagar orientation agar (BD) to differentiate Enterobacteriaceae and Enterococcus
isolates. All bacterial isolates were identified by matrix assisted laser desorption ionization—
time-of-flight (MALDI-TOF) mass spectrometry using a Bruker Microflex LT instrument
(Bruker Daltonics). Sadly, blood culture isolates are not routinely retained by the diagnostic
laboratory, hence were not available for whole genome sequencing as we would have wished.
Further comparison between faecal and blood isolates was therefore made using extended anti-
biograms. Where there was species concordance between the bacteria isolated from the faecal
sample and blood culture, the pure isolates were grown on Iso-Sensitest plates (Oxoid) and
appropriate extended antibiograms were performed according to the British Society for Anti-
microbial Chemotherapy standardised disc susceptibility protocol.[22] To test the discriminant
potential of this typing approach (as previously employed by Köser et al.[23]), we examined
antibiograms of all CoNS strains isolated from faecal samples collected from babies resident on
the NICU at the same time as one index CoNS LO-BSI case.
Statistical Analysis
Case and control patient characteristics were compared using Student’s t-tests and Chi-squared
tests or Fisher’s exact test where appropriate. The conditional logistic regression, generalised
linear model and stepwise functions of the R statistical package (version 3.0.2),[24] were used
to identify both OTUs that were differentially abundant and clinical and microbial discrimina-
tors between LO-BSI and control groups. Factors considered were the relative abundance of
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each of the top 6 OTUs (comprising 90% of total reads), total proportion of anaerobic organ-
isms, and three measures of microbial diversity (inverse Simpson index, Shannon-Weaver
index, Pielou’s evenness). Student’s t-tests (unequal variances) were used to compare OTU
count data.
Results
Patients
369 infants were recruited and 10,928 faecal samples collected. 30 infants were eligible LO-BSI
cases during the study period. Fig 1 illustrates the distribution of the cases over the 28 months;
infants who could not be included in the analyses are marked by vertical bars (18). The causa-
tive LO-BSI organisms are shown in Fig 1. There were no cases of fungal sepsis. Table 1 out-
lines the cohort clinical characteristics. Prior to diagnosis, compared to controls, infants who
developed LO-BSI: were lighter at birth (p = 0.04); required more days of mechanical ventila-
tion (p = 0.007); had more days with invasive lines (p = 0.003); more likely to have multiple
lines in situ (p = 0.001).
454 Pyrosequencing and initial data processing
An average of 2 samples per subject-week were analysed from the 44 ‘sequencing control’
infants to characterise the maturation of the normal GI microbiota. From each LO-BSI infant
weekly faecal samples from birth and a median of five faecal samples collected in the two weeks
prior to D0 were characterised. There were 434 and 153 samples successfully processed from
sequencing controls and LO-BSI infants respectively. After denoising and chimera removal
2,635,031 reads remained and were de-multiplexed. The mean number of reads was 4,489 per
sample. Singletons (sequences present only once in a sample) and OTUs present in only one
sample were removed. For maximum data retention, sample reads were rarefied to 800, with
rarefaction curves showing this to be sufficient to capture the OTU diversity as measured by
the Shannon diversity index (S1 Fig).
Bacterial communities in control samples
The most abundant OTUs (90% of reads) were Klebsiella, Staphylococcus, Enterococcus,
Escherichia, Clostridium and Bifidobacterium (data derived from one faecal sample per week
per sequencing control) (S2 Fig; for full data see S3 Fig). Bacterial communities evolve rapidly
with multiple OTUs having significantly varying differential abundance with postnatal age
(p<0.05) and by delivery method (p<0.05).
Anaerobic succession of the GI microbiota
OTUs were categorised as aerobes/facultative anaerobes (“aerotolerant”) and obligate anaer-
obes, based on NCBI annotations.[25] During the first week of life, there was no difference in
mean OTU reads between these two categories in infants who developed LO-BSI (n = 13) and
controls (n = 26). In older infants developing LO-BSI, and their controls, there was a signifi-
cantly higher proportion of obligate anaerobes one week prior to LO-BSI diagnosis in faecal
samples from the control group than from cases (p = 0.03) and this divergence was most
extreme in the samples collected closest to D0 (p = 0.01) (Fig 2).
The most abundant OTUs (90% of reads) in faecal samples collected closest to D0 in
LO-BSI cases were Klebsiella, Staphylococcus, Escherichia, Enterococcus and Clostridium (see
S4 Fig). Logistic regression indicated a significant association (p = 0.047) between abundant
Staphylococcus OTU reads in the first week of life (mean reads = 563 in cases (n = 13), 337 in
Preterm Sepsis and the GI Microbiota
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controls (n = 26)) and later LO-BSI. The development of the GI microbiota for each infant
with LO-BSI is shown in Fig 3.
Logistic regression
Anticipating differences in risk factors for LO-BSI caused by different bacteria, logistic regres-
sion was used in a first round of analysis to identify clinical factors (Table 1) and microbial
population signals that discriminated Enterobacteriaceae and “Other” (Enterococcus, GBS)
LO-BSI cases together from both Staphylococcal cases and Controls. Conditional univariate
analysis highlighted the presence of multiple lines (p = 0.006), lower weight at birth (p = 0.02),
lower gestational age at birth (p = 0.008), more days of mechanical ventilation (p = 0.03), and
more cumulative total number of days of each invasive line present (‘line days’) (p = 0.02), as
all being associated with Enterobacteriaceae and “Other” LO-BSI. These factors, together with
those significant at the 0.05< p< 0.1 level (‘trending factors’: number of Escherichia OTU
reads and cumulative days on antibiotics), were included in a multivariate analysis, using a
stepwise algorithm to retain key variables. Three factors were retained in the final model: the
presence of multiple lines, weight at birth, and number of Escherichia OTU reads.
Infants not identified in this first round of analysis were included in a second round, aiming
to discriminate staphylococcal LO-BSI cases from the rest. Conditional univariate analysis
highlighted more days of mechanical ventilation (p = 0.03), more days with any lines (p = 0.01)
and more cumulative ‘line days’ (p = 0.01). Multivariate analysis including trending factors
(number of Staphylococcus OTU reads) gave a final model retaining: days of mechanical venti-
lation, days with any lines and number of Staphylococcus OTU reads.
LO-BSI screening criteria
Using the risk factors identified by multivariate analysis, hierarchical clustering performed on
the dataset correctly classified 20/22 cases and 31/44 control infants (Fig 4).
The potential utility of this approach in defining risk depends crucially on inclusion of
microbiota data. A repeat of the two-stage analysis after its removal led to greatly lowered sen-
sitivity and specificity. If alternatively all LO-BSI cases are combined and compared to controls,
a multivariate model identifies risk associated with increased days of mechanical ventilation
Fig 1. Cumulative cases of LO-BSI over 28 months.Hatching indicates hospital site and whether
staphylococcal or other cause. Bar length indicates duration of infant admission; stars indicates date of
LO-BSI diagnosis. Marked cases were excluded from the analysis due to lack of samples (n = 6) or lack of
sequencing data (n = 2).
doi:10.1371/journal.pone.0132923.g001
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Table 1. Summary of the cohort demographics—LO-BSI cases andmatched controls.
Cases (n = 22) Controls
(n = 44)
Demographics
Male (%) 9 (41) 25 (57)
Mean birth weight (SD) (g) 813.0 (257.0)
(p = 0.04)
959.0 (266.4)
Mean gestation at birth (SD), days 183.6 (14.6) 190.0 (13.2)
Mean postnatal age at D-1 (SD), days 18.9 (15.2) 18.9 (15.2)
Admission hospital
Site A (%) 16 (73) 34 (77)
Site B (%) 6 (27) 10 (23)
Ethnicity
Black (%) 3 (14) 9 (20.5)
White (%) 8 (36) 23 (52)
Asian (%) 5 (23) 3 (7)
Mixed (%) 6 (27) 9 (20.5)
Mode of delivery
CS (%) 9 (41) 27 (61)
VD (%) 13 (59) 17 (39)
Maternal characteristics
Maternal infection during pregnancy (%) 3 (14) 5 (11)
Maternal IVAB use at delivery (%) 6 (27) 11 (25)
Maternal PROM (%) 6 (27) 11 (25)
Maternal sepsis/chorioamnionitis (%) 6 (27) 9 (20)
Intravenous antibiotic use
Intravenous antibiotics at given at birth (%) 6 (27) 11 (25)
Mean number of days of IVAB during ﬁrst week of life (SD), days 2.7 (1.9) 2.3 (1.8)
Mean number of cumulative days of IVAB use prior to D0 (SD),
days
4.0 (4.5) 2.8 (2.0)
Invasive lines
Mean number of days with an invasive line in situ prior to D0 (SD),
days
6.3 (4.1)
(p = 0.003)
3.1 (3.2)
Mean number of total days of each invasive line in situ prior to D0
(SD), days
8.1 (5.4)
(p = 0.002)
3.5 (3.9)
Presence of invasive line/s prior to D0 (%) 17 (77) (p = 0.01) 23 (52)
Presence of multiple invasive lines prior to D0 (%) 12 (55)
(p = 0.001)
9 (20.5)
Respiratory support requirement
Mean number of days requiring ventilation support (HFOV or
conventional ventilation) prior to D0 (SD), days
7.2 (8.6)
(p = 0.007)
1.5 (2.4)
Mean number of days requiring CPAP (no oxygen), prior to D0
(SD), days
4.3 (6.3) 7.1 (8.1)
Mean number of days requiring CPAP with supplemental oxygen,
prior to D0 (SD), days
4.9 (3.8) 5.0 (6.9)
Metadata related to sample closest to D0
Mean number of postnatal days sample closest to D0 analysed,
(SD)
17.5 (15.3) 18.0 (16.0)
(Continued)
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and more cumulative ‘line days’ with fewer false positives (correct classification of 40/44 con-
trols) but a reduced sensitivity (only 15 cases identified).
Culture and Antibiogram data
Antibiotic resistance profiles (extended antibiograms) had been determined for the organisms
isolated from the bloodstream of 21 LO-BSI infants (information on the isolate from infant
B16 was not available). Faecal samples collected closest to D0 from these infants yielded
microbes with antibiograms that matched the bloodstream isolate in 12 cases (Fig 5), compared
to only 3 matches to the index case bloodstream isolate in microbes isolated from culture con-
trol infants (p = 0.01). In consideration of the possibility that matches between bloodstream
and faecal isolates might be a chance finding, the antibiogram of the bloodstream isolate from
one CoNS LO-BSI case (B18) was compared to those of microbes isolated by selective culture
for CoNS from faecal samples collected from all eight contemporaneous residents on the same
NICU site. Fourteen morphologically distinct isolates were recovered from these babies, and
extended antibiograms were established for each. Eleven different profiles were observed, but
none matched the LO-BSI organism isolated from B18. We infer that antibiograms matching
between faecal and bloodstream isolates in a septic infant may reflect bacterial translocation
between GI tract and the circulation.
Discussion
We have found that the occurrence of LO-BSI in premature infants is correlated with an aber-
rant development of the GI microbiota as reflected in faecal composition—a delay, or a rever-
sal, in the shift to anaerobiosis. In newborn infants the initial GI microbiota is aerotolerant, but
becomes increasingly dominated by anaerobes over the first weeks/months of life,[26] a process
that appears to occur more gradually in healthy premature infants.[27–30] In our population
of premature infants who developed LO-BSI, Staphylococcus and/or Gram-negative enteric
OTUs dominate the GI microbiota right up to the time of the diagnosis of sepsis, as long as sev-
eral weeks after birth. Staphylococcal prominence in the faecal microbiota has been noted in
neonatal sepsis in one other small 16S gene sequencing study,[31] while Mai et al., [32] using
the same approach, reported a bloom of Gram-negative enteric organisms shortly before the
diagnosis of LO-BSI in premature infants.
What might the mechanism be? S. aureus has been shown to perturb the normal microbiota
of the human colon, reducing the proportion of anaerobic species such as Bifidobacterium and
Lactobacillus,[33] often employed in probiotic formulations. This may explain the disappoint-
ing lack of efficacy of trials of probiotics in the prevention of LO-BSI.[34 The immaturity of the
Table 1. (Continued)
Cases (n = 22) Controls
(n = 44)
Mean weight closest to D0, (SD) (g) 899.5 (459.2) 1052.7
(431.7)
Abbreviations—SD, standard deviation; D-1, day prior to diagnosis, D0, day of LO-BSI diagnosis or
postnatal age of matched control; CS, Caesarean-section; VD, vaginal delivery; IVAB, intravenous
antibiotics; PROM, prolonged rupture of membranes; HFOV, high frequency oscillation ventilation; CPAP,
continuous positive airways pressure. P values of signiﬁcant differences between LO-BSI cases and
controls are denoted in bold
doi:10.1371/journal.pone.0132923.t001
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infant, with potential oxygenation of the GI tract through a leaky epithelium, and the NICU
setting itself (antibiotic treatments and oxygen-rich ventilation) may also contribute to this
lack of anaerobic progression.
It has had been demonstrated that some obligate anaerobes prevent bacterial translocation
by increasing epithelial integrity.[35, 36] Additionally, the absence of anaerobic bacteria
increases the risk that facultative anaerobes may translocate across the intestinal barrier [37]–
either the predominant staphylococci/Enterobacteriaceae present, or other components of the
microbiota. In our study twelve infants’ infections fell into the first of these categories—seven
Fig 2. Bacterial faecal community structure developing prior to D0. Data generated using one sample weekly from LO-BSI infants and controls. Black
lines on the stacked bars divide the identified OTUs: lower segment comprises aerobes/facultative anaerobes, upper segment obligate anaerobes.
doi:10.1371/journal.pone.0132923.g002
Fig 3. Development of the faecal microbiota in infants with LO-BSI. Bar charts are identified by the infant ID and the microbe cultured from the blood.
Stacked bars show composition of faecal microbiota on days indicated (x-axis). Red stars indicate the day of life of LO-BSI diagnosis.
doi:10.1371/journal.pone.0132923.g003
Preterm Sepsis and the GI Microbiota
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suffering from staphylococcal bloodstream infection (five S. aureus, two CoNS), and five with
Gram-negative sepsis. The organism from the bloodstream was indistinguishable from a domi-
nant component of their faecal microbiota. In the second category, one infant with enterococ-
cal LO-BSI had the same enterococcus as a minor component of his staphylococcal-dominated
faecal microbiota. In the remaining nine infants the source of the bloodstream infection was
not clear. Possibilities to consider included the GI microbiota, the skin (breached by invasive
lines) and the intubated airway. In three cases where the bacterial species responsible for blood-
stream infection could not be detected in the faecal microbiota, there were clear risk factors for
infection elsewhere—invasive lines and mechanical ventilation. In two further cases (both
caused by CoNS) where there were no such risk factors, the faecal microbiota were dominated
by a Staphylococcus OTU. It may be that the mismatch of antibiograms between the blood-
stream isolate and the faecal isolate examined simply reflected a failure to capture a relatively
minor component of the faecal microbiota. The collection of swabs and aspirates to character-
ize the epidermal and pulmonary microbiota, in addition to swabs of line insertion sites and
indwelling devices, could further clarify potential sources of infection. This wealth of informa-
tion could also allow the investigation of interactions between the microbiota at both environ-
mental interfaces and different body sites.
Carl et al.[38] demonstrated an origin in the GI microbiota for organisms responsible for 7/
11 cases of LO-BSI in a VLBW infant cohort, but did not consider staphylococcal bloodstream
Fig 4. Clustering of LO-BSI cases and controls into risk groups. Three heat maps display clinical
information on the day prior to diagnosis, and sequencing information from the faecal sample closest to D0. A
distinct cluster of infants at high risk of Enterobacteriaceae and “Other” LO-BSI is indicated. Infants not within
this category undergo a second round of screening, identifying infants at high risk of Staphylococcal LO-BSI.
doi:10.1371/journal.pone.0132923.g004
Preterm Sepsis and the GI Microbiota
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infection relevant, regarding these as most likely originating from the skin. While CoNS are
indeed common skin colonists,[2, 4] detailed typing of strains collected from multiple sites in
individual patients has demonstrated that blood isolates often match mucosal rather than skin
strains.[39] Indeed, S. epidermidis (a coagulase negative Staphylococcus) has been shown to
translocate from the gut with the same efficiency as E. coli and more readily than K. pneumo-
niae in a mouse model.[40] The seven infants in our study with staphylococcal LO-BSI, where
the causative strain was also identified in the faecal microbiota, attest to the fact that staphylo-
coccal LO-BSI may commonly arise by translocation of organisms from a GI microbiota
habitat.
LO-BSI is an important cause of mortality and morbidity in preterm infants, and our study
implicates the GI microbiota as an important reservoir of infection, not only for Gram-negative
organisms, but also for staphylococci. This focuses attention on strategies for the timely detec-
tion of GI dysbiosis. Should they be translated to a diagnostic test, our results suggest that it
should be possible to identify babies who are destined develop LO-BSI with a sensitivity of 91%
and specificity of 70%, out-performing single CRP measurements in the prediction of late
onset sepsis.[41] Our analysis identified significant features both in the composition of the
microbiota and a failure to mature—persistent staphylococci and Enterobacteriaceae and pau-
city of obligate anaerobes—which, whilst not necessarily causal, are correlated with a progres-
sion to LO-BSI. At present, conducting complete microbiota analysis in a manner timely
enough to impact infant management is not practical. This study however points the way
towards development of specific surveillance tools, such as organism-targeted qPCR, to
monitor the maturation of the GI microbiota, perhaps combined with strategies to alter the
microbiota to a “safer” composition. This could be achieved through modulation of the gut
microbiota by treatments shown to reduce LO-BSI (such as lactoferrin),[42] the judicious use
of probiotics accompanied by a selective decontamination protocol, or by more radical
bacteriotherapy.
Fig 5. Antibiogram concordance of isolates found in faecal samples of LO-BSI infants and contemporaneous controls. Table aligns antibiograms of
blood isolate (BI), corresponding faecal isolate (B) and isolates from the contemporaneous control (C). R indicates antibiotic resistance. In two cases faecal
samples from controls contained two different staphylococcal strains: both antibiograms are shown.
doi:10.1371/journal.pone.0132923.g005
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Supporting Information
S1 Fig. Rarefaction curves for sequencing data. A randomised selection of 10% of the rarefac-
tion curves for the dataset. Black dashed line shows the chosen cut off value for rarefaction.
(TIF)
S2 Fig. Bacterial fecal community structure in control infants by postnatal week and mode
of delivery. Data generated using one sample per week from sequencing control infants. When
the same descriptive label (genus, family) is attached to multiple OTUs, these are numbered
sequentially—no OTUs are combined.
(TIF)
S3 Fig. The GI microbiota of 44 control infants. Samples are categorised along the x axis,
grouped by infant and then chronologically with the earliest sample on the left. Infants are
grouped by admission hospital. Colour intensity indicates the number of rarefied reads from
each OTU that are found in a sample, as shown by the coloured bar.
(TIF)
S4 Fig. Heat map of bacterial communities in fecal samples collected closest to D0 from
LO-BSI infants and their matched controls. LO-BSI infant samples are grouped by LO-BSI
organisms and sequencing control samples according to LO-BSI organism of their matched
case. Color intensity indicates number of rarefied reads from each OTU in a sample.
(TIF)
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